Partial Breast Reconstruction and Oncoplasty: Our Experience

Authors

  • Aqsa Saleema Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Maria Mir Jan Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Zohra Jabeen Akram Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Zaini Azam Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Shandana Gul Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Syeda Rifaat Qamar Naqvi Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-7.12763

Keywords:

Breast Neoplasm, Breast Surgery, Oncoplastic breast surgery, Partial Breast Reconstruction, Treatment Outcome

Abstract

Objective: To evaluate outcomes of partial breast reconstruction and oncoplastic procedure in a tertiary care setup.

Study Design: Prospective observational study.

Place and Duration of Study: Combined Military Hospital Rawalpindi, Pakistan from Jan 2023 to Jun 2024.

Methodology: In this study, 46 patients were included who had benign or malignant breast tumor with high tumor to breast ratio, requiring surgical excision when adequate downsizing was not achieved or was not possible with primary systemic therapy, were offered breast oncoplastic surgery. Each case underwent Triple Assessment and discussed in Multi-Disciplinary Meeting. All cases were staged using American Joint Committee on Cancer (AJCC) staging system. Clinically T4 and metastatic disease patients were excluded. Patients were followed for post operative complications including bleeding, infection, flap necrosis, seroma formation, fat necrosis, length of hospital stay and recurrence, and evaluated for aesthetic outcomes.

Results: This study included total of 46 patients with a mean age of 47 years. Majority of patients had clinical T2 tumor and stage 2 disease. Most patients were luminal A type or DCIS, and upfront surgery was performed. Early post operative complications include bleeding and hematoma formation in 4.3% of patients, wound infection in 9.3 %, 4.3% had wound dehiscence. Mean hospital stay was 3 days, and none required re-admission for any complication encountered.

Conclusion: Oncoplastic breast surgery, despite its associated early postoperative complications, achieves good aesthetic outcomes and is oncologically safe across all age group and surgical setting.

Downloads

Download data is not yet available.

Author Biography

  • Maria Mir Jan, Department of Breast Surgery, Combined Military Hospital Rawalpindi/National University of Medical Sciences (NUMS) Pakistan

     

     

References

1. Asif HM, Sultana S, Akhtar N, Rehman JU, Rehman RU. Prevalence, risk factors and disease knowledge of breast cancer in Pakistan. Asian Pac j cancer prev 2014; 15(11): 4411-4416.

https://doi.org/10.7314/apjcp.2014.15.11.4411

2. Tassang A, Brady RM, Fru CN, Yinka T, Thierry T, Musa IH, et al. Breast cancer and prevention perspectives: A public health challenge, Buea regional hospital, Cameroon. GSC Adv Res Rev 2022; 13(2): 258-268. https://doi.org/10.30574/gscarr.2022.13.2.0327

3. Burguin A, Diorio C, Durocher F. Breast cancer treatments: updates and new challenges. J Pers Med 2021; 11(8): 808.

https://doi.org/10.3390/jpm11080808

4. Azam Z, Gul S, Jan MM, Tariq M, Saleema A, Naqvi SRQ, et al. The Factors Impacting Decision-Making for Breast Reconstruction in Women Following Mastectomy: A Cross-Sectional Study. J Gandhara Med Dent Sci 2024; 11(2): 47-50.https://doi.org/10.37762/jgmds.11-2.547

5. Hasan MT, Hamouda M, Khashab MKE, Elsnhory AB, Elghamry AM, Hassan OA, et al. Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients. Breast Cancer 2023; 30(2): 200-214.

https://doi.org/10.1007/s12282-022-01430-5

6. Nanda A, Hu J, Hodgkinson S, Ali S, Rainsbury R, Roy PG. Oncoplastic breast‐conserving surgery for women with primary breast cancer. Cochrane Database Syst Rev 2021(10): CD013658.

https://doi.org/10.1002/14651858.cd013658.pub2

7. Gilmour A, Cutress R, Gandhi A, Harcourt D, Little K, Mansell J, et al. Oncoplastic breast surgery: A guide to good practice. Eur J Surg Oncol 2021; 47(9): 2272-2285.

https://doi.org/10.1016/j.ejso.2021.05.006

8. Zaha H. Partial breast reconstruction for the medial quadrants using the omental flap. Ann Surg Oncol 2014; 21: 3358.

https://doi.org/10.1245/s10434-014-3907-z

9. Escandón JM, Escandón L, Ahmed A, Weiss A, Nazerali R, Ciudad P, et al. Breast reconstruction using the Latissimus Dorsi Flap and Immediate Fat Transfer (LIFT): A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 2022; 75(11): 4106-4116.

https://doi.org/10.1016/j.bjps.2022.08.025

10. McCulley SJ, Schaverien MV, Tan VK, Macmillan RD. Lateral thoracic artery perforator (LTAP) flap in partial breast reconstruction. J Plast Reconstr Aesthet Surg 2015; 68(5): 686-691.

https://doi.org/10.1016/j.bjps.2015.01.008

11. Vohra LM, Farooqi N, Jiwani U, Ali D. Outcomes of oncoplastic breast surgery compared to breast-conserving surgery in breast cancer patients in a developing country: a retrospective cohort study. Pak J Med Sci 2024; 40(1Part-I): 8-13.

https://doi.org/10.12669/pjms.40.1.7360

12. Nakhlis F. Oncoplastic Breast surgery–pros and cons for the breast surgical oncologist. Arch Breast Cancer 2020:97-99.

https://doi.org/ 10.32768/abc.20207397-99

13. Rasmussen LF, Kiilerich CH, Trøstrup H, Hansen LB. Surgical outcomes and complications: a study comparing oncoplastic surgery and lumpectomy. Ann Breast Surg 2024; 8: 24.

https://doi.org/ 10.21037/abs-23-69

14. Kosasih S, Tayeh S, Mokbel K, Kasem A. Is oncoplastic breast conserving surgery oncologically safe? A meta-analysis of 18,103 patients. Am J Surg 2020; 220(2): 385-392.

https://doi.org/10.1016/j.amjsurg.2019.12.019

15. Blok Y, Verduijn P, Corion L, Visser J, van der Pol C, van der Hage J, et al. An analysis of complication rates and the influence on patient satisfaction and cosmetic outcomes following oncoplastic breast surgery. J Plast Reconstr Aesthet Surg 2022; 75(11): 4152-4159.

https://doi.org/10.1016/j.bjps.2022.06.088

16. Mehmood M, Aslam A, Ahmed W, Aman S, Ali A, Feroze H, et al. Awareness and Acceptability of Breast Reconstruction Among Women with Breast Cancer in Twin Cities of Islamabad and Rawalpindi. Life Sci 2024; 5(1): 9-15.

https://doi.org/10.37185/LnS.1.1.509

17. Rizvi FH, Khan MK, Almas T, Ullah M, Shafi A, Murad MF, et al. Early Postoperative Outcomes of Breast Cancer Surgery in a Developing Country. Cureus 2020; 12(8): e9941.

https://doi.org/10.7759/cureus.9941

18. Crown A, Handy N, Rocha FG, Grumley JW. Oncoplastic reduction mammaplasty, an effective and safe method of breast conservation. Am J Surg 2018; 215(5): 910-915.

https://doi.org/10.1016/j.amjsurg.2018.02.024

19. Morrow ES, Stallard S, Doughty J, Malyon A, Barber M, Dixon JM, et al. Oncoplastic breast conservation occupies a niche between standard breast conservation and mastectomy – A population-based prospective audit in Scotland. Eur J Surg Oncol 2019; 45(10): 1806-1811.

https://doi.org/10.1016/j.ejso.2019.03.014

20. André C, Holsti C, Svenner A, Sackey H, Oikonomou I, Appelgren M, et al. Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer. BJS Open 2021; 5(1): zraa013. https://doi.org/10.1093/bjsopen/zraa013

Published

15-07-2026

Issue

Section

Original Articles

Categories

How to Cite

1.
Saleema A, Jan MM, Akram ZJ, Azam Z, Gul S, Naqvi SRQ. Partial Breast Reconstruction and Oncoplasty: Our Experience. Pak Armed Forces Med J [Internet]. 2026 Jul. 15 [cited 2026 Jul. 22];76(SUPPL-7). Available from: https://www.pafmj.org/PAFMJ/article/view/12763